Clinical usefulness of tumor mutational burden (TMB) assessed by NGS in solid tumors

被引：0
|
作者：
Kim, H. [1 ]
Kim, S. T. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Hematol Oncol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [1] Clinical Validation of Tumor Mutational Burden (TMB) in Solid Tumors by NGS: Impact of Revised TMB-High Threshold
    Parimi , Vamsi
    Xian, Rena
    Lin, Ming-Tseh
    Eshleman, James
    Gocke, Christopher
    Pallavajjala, Aparna
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1071 - 1072
  • [2] Clinical Validation of Tumor Mutational Burden (TMB) in Solid Tumors by NGS: Impact of Revised TMB-High Threshold
    Parimi , Vamsi
    Xian, Rena
    Lin, Ming-Tseh
    Eshleman, James
    Gocke, Christopher
    Pallavajjala, Aparna
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1071 - 1072
  • [3] Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors
    Kao, Chester
    Powers, Eric
    Datto, Michael B.
    Green, Michelle
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Clarke, Jeffrey Melson
    Strickler, John H.
    Zhang, Tian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [4] Tumor Mutational Burden Testing in Solid Tumors
    Kwon, Regina
    Cheng, Heather H.
    Pritchard, Colin C.
    [J]. JAMA ONCOLOGY, 2023, 9 (12) : 1725 - 1726
  • [5] Tumor Mutational Burden (TMB) Scoring in Pediatric Tumors Using a Comprehensive Clinical Genomics Sequencing Approach
    Cardenas, M.
    Wang, L.
    Ma, J.
    Payne-Turner, D.
    Gu, J.
    Conn, P.
    Wallace, R.
    Howell, S.
    Neary, J.
    Pastor, V.
    Shi, Z.
    Smith, M.
    Haltom, K.
    Shumaker, S.
    Messler, K.
    Koo, S.
    Blackburn, P.
    Liu, Y.
    Eldomery, M.
    Rusch, M.
    Furtado, L.
    Klco, J.
    Mallampati, S.
    Wheeler, D.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S82 - S82
  • [6] Efficacy of atezolizumab in the treatment of solid tumors with high tumor mutational burden (TMB): A MyPathway study cohort.
    Hainsworth, John
    Friedman, Claire F.
    Kurzrock, Razelle
    Spigel, David R.
    Burris, Howard
    Sweeney, Christopher J.
    Meric-Bernstam, Funda
    Wang, Yong
    Levy, Jonathan
    Shames, David
    Schulze, Katja
    Patel, Arisha
    Swanton, Charles
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [7] Calculation of Mutational Burden in a Clinical Targeted Next-Generation Sequencing (NGS) Panel for Solid Tumors
    Velu, P.
    Bigdeli, A.
    Hess, P. R.
    Roth, J. J.
    Rosenbaum, J. N.
    Morrissette, J. J.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1024 - 1025
  • [8] Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
    Sha, Dan
    Jin, Zhaohui
    Budczies, Jan
    Kluck, Klaus
    Stenzinger, Albrecht
    Sinicrope, Frank A.
    [J]. CANCER DISCOVERY, 2020, 10 (12) : 1808 - 1825
  • [9] Tumor mutational burden (TMB) standardization initiative: Establishing a consistent methodology for TMB measurement in clinical samples
    Stenzinger, A.
    Allen, J.
    Maas, J.
    Stewart, M.
    Merino, D.
    Dietel, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [10] Utilizing 486 gene assay on a NGS platform to validate guideline-adherent tumor mutational burden (TMB) module to calculate TMB
    Ahluwalia, Pankaj K.
    Mondal, Ashis
    Ananth, Sudha
    Heneidi, Saleh
    Kota, Vamsi
    Kolhe, Ravindra
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345